Hepatitis B News and Research

Latest Hepatitis B News and Research

Researchers use integrated data analysis to classify liver cancer

Liver cancer remains a major problem in healthcare globally, being the second most common cause of cancer-related death globally.

3 Feb 2019

New research collaboration between EU and Russia focuses on infectious diseases

A new EU project on the theme of HIV, hepatitis C and tuberculosis is a door opener for collaboration between researchers from EU countries and Russia.

28 Jan 2019

Standard method for ranking liver transplant waitlists may not prioritize the sickest candidates

A new study has uncovered that the standard method for ranking patients on the waitlist for lifesaving liver transplantation may not prioritize some of the sickest candidates for the top of the list.

25 Jan 2019

Study reveals cost-effectiveness of needle and syringe programs in preventing HCV transmission

Providing clean injecting equipment through needle and syringe programmes is a highly cost-effective way of preventing hepatitis C transmission among people who inject drugs and could save millions of pounds in infection treatment costs in the UK, according to research led by the University of Bristol and London School of Hygiene & Tropical Medicine.

24 Jan 2019

Trump zeroes in on surprise medical bills in White House chat with patients, experts

President Donald Trump on Wednesday instructed administration officials to investigate how to prevent surprise medical bills, broadening his focus on drug prices to include other issues of price transparency in health care.

23 Jan 2019

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

Hologic, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted clearance for its Aptima Mycoplasma genitalium assay, the first and only FDA-cleared test to detect this under-recognized but increasingly common sexually transmitted infection (STI).

23 Jan 2019

Alcohol-linked disease overtakes hep C as top reason for liver transplant

An estimated 17,000 Americans are on the waiting list for a liver transplant, and there's a strong chance that many of them have alcohol-associated liver disease. ALD now edges out hepatitis C as the No. 1 reason for liver transplants in the United States, according to research published Tuesday in JAMA Internal Medicine.

23 Jan 2019

Hepatitis C-infected patients with a history of liver cancer can be treated with antivirals

A large, multi-center study refutes earlier suggestions that antiviral drugs for treating hepatitis C may lead to a higher recurrence of liver cancer.

18 Jan 2019

Many cancer patients have undiagnosed hepatitis

A new report has described an alarmingly high rate of undiagnosed acute and chronic hepatitis B and hepatitis C in patients with cancer.

17 Jan 2019

Research suggests possible way to improve survival in African-Americans undergoing liver transplant

Among African-American adults undergoing liver transplant to treat liver cancer, patients whose organ donor was also African-American lived significantly longer than those with a racially unmatched donor, report authors of a new study using national data.

10 Jan 2019

NYSCF announce partnership with Ngene to develop new disease treatments

The New York Stem Cell Foundation Research Institute today announced a partnership with Ngene Therapeutics Inc. to develop new disease treatments that leverage human stem cell research and novel gene editing techniques.

10 Jan 2019

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Drugs that can cure hepatitis C revolutionized care for millions of Americans living with the deadly liver infection. The drugs came with a steep price tag — one that prompted state Medicaid programs to initially limit access to the medications to only the sickest patients.

4 Jan 2019

Court decision to stop further cuts in 340B reimbursements protects patient care

The Dec. 27 federal court injunction stopping further cuts in 340B reimbursements for Medicare Part B drugs to some participating hospitals is a critical step in preserving the role that academic health centers play in providing HIV, viral hepatitis, and other infectious disease treatment and prevention services to patients who otherwise lack care options.

2 Jan 2019

Himalayan marmot genome offers clues to high-altitude adaptation

Himalayan marmots can survive at altitudes up to 5,000 meters in the Himalayan regions of India, Nepal, and Pakistan and on the Qinghai-Tibetan Plateau of China, where many of them face extreme cold, little oxygen, and few other resources.

27 Dec 2018

Study reveals how Hepatitis C infection varies by state and region

Hepatitis C virus infection is a major cause of illness and death in the United States and injection drug use is likely fueling many new cases.

24 Dec 2018

Researchers synthesize new compound that inhibits replication of hepatitis C virus

A new compound that inhibits the replication of hepatitis C virus in several stages of its lifecycle - and is also capable of acting on bacteria, fungi and cancer cells - has been synthesized by researchers at São Paulo State University in Brazil.

19 Dec 2018

Viral hepatitis: Liver failure caused by defects in the vascular system

In severe cases, a viral hepatitis infection can result in liver failure. A team from the Technical University of Munich has now discovered how this occurs: by immune cells attacking cells in the vascular system, which disrupts the organ's blood and nutrient supply.

19 Dec 2018

Hepatitis B News and Research

Latest Hepatitis B News and Research

Researchers use integrated data analysis to classify liver cancer

New research collaboration between EU and Russia focuses on infectious diseases

Standard method for ranking liver transplant waitlists may not prioritize the sickest candidates

Study reveals cost-effectiveness of needle and syringe programs in preventing HCV transmission

Trump zeroes in on surprise medical bills in White House chat with patients, experts

FDA grants clearance to Hologic’s assay for detection of common sexually transmitted infections

Alcohol-linked disease overtakes hep C as top reason for liver transplant

Hepatitis C-infected patients with a history of liver cancer can be treated with antivirals

Many cancer patients have undiagnosed hepatitis

Research suggests possible way to improve survival in African-Americans undergoing liver transplant

NYSCF announce partnership with Ngene to develop new disease treatments

Medicaid patients in Puerto Rico don’t get coverage for drugs to cure hepatitis C

Court decision to stop further cuts in 340B reimbursements protects patient care

Himalayan marmot genome offers clues to high-altitude adaptation

Study reveals how Hepatitis C infection varies by state and region

Researchers synthesize new compound that inhibits replication of hepatitis C virus

Viral hepatitis: Liver failure caused by defects in the vascular system

Hep C and drug abuse often go hand in hand, but screening for infection lags

Hepatitis C drug can eliminate chikungunya, yellow fever virus

Chronic fatigue syndrome connected with an overactive immune system

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Hepatitis B News and Research

Latest Hepatitis B News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in